Target intelligence / Profile preview

RBMS3 antisense RNA 1 (RBMS3-AS1)

Target: RBMS3-AS1
Molecular classification: Long non-coding RNA (lncRNA), Antisense RNA

Overview

RBMS3 antisense RNA 1 (RBMS3-AS1) is a long non-coding RNA (lncRNA) gene located on chromosome 3 and transcribed in the antisense direction relative to the RBMS3 gene[3][9]. It does not encode a protein product and to date, its biological roles, disease relevance, and clinical or experimental significance remain uncharacterized in the scientific literature. Unlike the protein-coding RBMS3 gene, which is implicated in tumor suppression, EMT, and various physiological processes[1][2][4][7], there is presently no substantial evidence attributing functional or pathological impact to RBMS3-AS1.

Other names: RBMS3 antisense RNA 1 (non-protein coding)

Mechanism of action

None known

Beyond the preview

Go deeper on RBMS3 antisense RNA 1 (RBMS3-AS1).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Explore the programs pursuing this target and their development progress.

Drug candidates
Developers
Development stage

Clinical trials

Follow the clinical studies evaluating therapies directed at this target.

Trial design
Status
Readouts

Competitive landscape

Compare approaches across drug candidates, modalities, and indications.

Programs
Modalities
Indications

Literature & evidence

Investigate the research and source evidence behind target biology and development.

Publications
Sources
Analysis

Patents

Explore patent activity around therapies and technologies addressing this target.

Patents
Assignees
Technologies

Research & analysis

Connect target biology, drug development, and emerging evidence in your research.

Biology
Development news
Analysis

Bring the full picture into focus.

See how Gosset can support your research on RBMS3 antisense RNA 1 (RBMS3-AS1).

Explore the full profile